Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D

被引：88

作者：

Mulhern, Brendan ^{[1
]}

Mukuria, Clara ^{[1
]}

Barkham, Michael ^{[2
]}

Knapp, Martin ^{[3
,4
]}

Byford, Sarah ^{[3
]}

Soeteman, Djora ^{[5
]}

Brazier, John ^{[1
]}

机构：

[1] Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England

[2] Univ Sheffield, Ctr Psychol Serv Res, Dept Psychol, Sheffield S1 4DA, S Yorkshire, England

[3] Kings Coll London, Ctr Econ Mental & Phys Hlth, London WC2R 2LS, England

[4] Univ London London Sch Econ & Polit Sci, Personal Social Serv Res Unit, London WC2A 2AE, England

[5] Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA

来源：

BRITISH JOURNAL OF PSYCHIATRY | 2014年 / 205卷 / 03期

关键词：

COGNITIVE-BEHAVIOR THERAPY; DELIBERATE SELF-HARM; COST-EFFECTIVENESS; SCHIZOPHRENIA; UTILITY; SCALE; DEPRESSION; DISEASE; PEOPLE; BURDEN;

D O I：

10.1192/bjp.bp.112.122283

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Background Generic preference-based measures (EuroQoL-5D (EQ-5D) and SF-6D) are used in the economic evaluation of mental health interventions. However, there are inconsistent findings regarding their psychometric properties. Aims To investigate the psychometric properties of the EQ-5D and SF-6D in different mental health conditions, using seven existing data-sets. Method The construct validity and responsiveness of the measures were assessed in comparison with condition-specific indicators. Results Evidence for construct validity and responsiveness in common mental health and personality disorders was found (correlations 0.22-0.64; effect sizes 0.37-1.24; standardised response means 0.45-1.31). There was some evidence for validity in schizophrenia (correlations 0.05-0.43), but responsiveness was unclear. Conclusions EQ-5D and SF-6D can be used in the economic evaluation of interventions for common mental health problems with some confidence. In schizophrenia, a preference-based measure focused on the impact of mental health should be considered.

引用

页码：236 / 243

页数：8

共 50 条

[31] Comparing SF-6D and EQ-5D utilities across groups differing in health status
Kontodimopoulos, Nick
Pappa, Evelina
Papadopoulos, Angelos A.
Tountas, Yannis
Niakas, Dimitris
[J]. QUALITY OF LIFE RESEARCH, 2009, 18 (01) : 87 - 97
[32] Comparing SF-6D and EQ-5D utilities across groups differing in health status
Nick Kontodimopoulos
Evelina Pappa
Angelos A. Papadopoulos
Yannis Tountas
Dimitris Niakas
[J]. Quality of Life Research, 2009, 18 : 87 - 97
[33] THE PSYCHOMETRIC PERFORMANCE OF THE EQ-5D, SF-6D AND DIABETES HEALTH PROFILE (DHP-18) IN TYPE 2 DIABETES
Mulhern, B.
Churchman, D.
Meadows, K.
[J]. VALUE IN HEALTH, 2012, 15 (07) : A504 - A504
[34] Use of a preference-based measure of health (EQ-5D) in COPD and asthma
Pickard, A. Simon
Wilke, Caitlyn
Jung, Eunmi
Patel, Sneh
Stavem, Knut
Lee, Todd A.
[J]. RESPIRATORY MEDICINE, 2008, 102 (04) : 519 - 536
[35] A comparison of the EQ-5D and the SF-6D in patients with pulmonary arterial hypertension
Brown, MC
[J]. VALUE IN HEALTH, 2005, 8 (06) : A4 - A4
[36] Comparing the Performance of the SF-6D and the EQ-5D in Different Patient Groups
Ferreira, Lara N.
Ferreira, Pedro L.
Pereira, Luis N.
[J]. ACTA MEDICA PORTUGUESA, 2014, 27 (02): : 236 - 245
[37] DEVELOPMENT OF A PREFERENCE-BASED INSTRUMENT: COMPARED WITH EQ-5D
Park, J.
Ahn, J.
Jo, M.
Shin, S.
Suh, J.
Cho, S.
Ock, M.
Lee, H.
[J]. VALUE IN HEALTH, 2015, 18 (07) : A713 - A713
[38] Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
Henk F van Stel
Erik Buskens
[J]. Health and Quality of Life Outcomes, 4
[39] A comparison of the EQ-5D and SF-6D across seven patient groups
Brazier, J
Roberts, J
Tsuchiya, A
Busschbach, J
[J]. HEALTH ECONOMICS, 2004, 13 (09) : 873 - 884
[40] Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
van Stel, Henk F.
Buskens, Erik
[J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2006, 4 (1)

← 1 2 3 4 5 →